1 unknown. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Unknown 1 |
Follow Hormone Refractory Prostate Cancer: new trials by email Literature Review of Hormone Refractory Prostate Cancer trials Research Report on Hormone Refractory Prostate Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Molecular Phenotype Changes and Personalized Treatment for CRPC Docetaxel & Prednisone, DP & Targeted drugs, cisplatin & Etoposide - Hormone Refractory Prostate Cancer | Not applicable | Unknown | Tianjin Medical University Cancer Institute and Hospital | 150 | 2014-06-01 | 2014-08-05 |
Cisplatin (1) · Docetaxel (1) · Etoposide (1) · Injections (1) · PE regimen (1) · Prednisone (1)
Tianjin Medical University Cancer Institute and Hospital (1)
China (1)